The call ran from 10:59 AM to 11:46 AM IST (47 min).

Key takeaways

Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.

Highlights
Revenue growth	Q2 revenue ₹135.6 Cr, +14.1% YoY, volume-driven.
Margins	EBITDA margin 21.5% Q2, +150bps YoY; H1 21%, +221bps.
Demand visibility	International patient flow slowly recovering; Bangladesh visa requests rising.
Management confidence	Balanced-to-optimistic; FY27 growth reiterated, Raipur timelines slipped.

Growth

Revenue +14.1%, EBITDA +23.9%, PAT +45.2% YoY; growth volume-led (~11% patient volume) with ARPOB +7.1%, occupancy 50.3% vs 47.4%.

Outlook

FY27 growth guided at 15-16% (metric unspecified); Raipur FY27 loss ~₹10 Cr; Jamshedpur 155 beds, Mar-Apr 2027.

Risks

Raipur ~₹9 Cr Q2 loss and slipped break-even; Artemis entry caused talent attrition; Supreme Court trade-margin ruling pending.

Last quarter's promises, checked

Delivered

EBITDA 'improve vs last year' → EBITDA +23.9% YoY (= BEAT)

Partly delivered

FY27 EBITDA margin ~21% (+200bps) → H1 21.0%, +221bps (= PARTIAL, FY not closed)
Jamshedpur 155 beds 'late Q4 FY27' → now Mar–Apr 2027 (= PARTIAL)

Missed

Raipur Q1 loss ₹3 Cr, 'taper through year' → Q2 loss ~₹9 Cr (= MISS)
Raipur breakeven ~20-month mark → slipped to Q1 FY28 (= MISS)

Summary by ALFA Finder, written with AI assistance from the earnings call transcript the company filed, published 6 Nov 2026, 1:47 PM IST. Open it on ALFA Filings ›

The results behind this call

5 Nov 2026 16:44 IST BSE

Financial Results

GPT Healthcare Q2 FY27 Results: Net Profit ₹15.4 Cr, Up 45.3% YoY

GPT Healthcare approved unaudited Q2 and half-year results, with H1 revenue of Rs 26,182.60 lakh. A 10% interim dividend was declared with a November 12 record date.